Top News

September 02, 2022

Novo Nordisk’s $1.1 billion acquisition of Forma Therapeutics is intended to expand its sickle cell and rare blood disorder portfolio.

September 02, 2022

FDA has issued an emergency use authorization for both the Pfizer-BioNTech and Moderna bivalent COVID-19 boosters.

August 30, 2022

Novavax’s COVID-19 vaccine, Nuvaxovid, can now be given to adolescents aged 12 to 17 in the UK.

August 29, 2022

The European Union publishes long-awaited changes to Annex 1.

August 29, 2022

Moderna is suing Pfizer and BioNTech for allegedly infringing on patents the company filed from 2010 to 2016.

August 15, 2022

The United Kingdom has approved Moderna’s bivalent COVID-19 vaccine, which targets the original variant and Omicron.

August 10, 2022

Pfizer’s $5.4 billion acquisition of Global Blood Therapeutics is expected to strengthen its sickle cell disease portfolio.

July 25, 2022

WHO has determined that monkeypox constitutes a public health emergency of international concern.

July 18, 2022

Royalty Pharma is paying $1.6 billion for the royalty rights to Trelegy Ellipta, a treatment for COPD and asthma.

July 18, 2022

FDA has granted an Emergency Use Authorization to Novavax’s COVID-19 vaccine.